Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overviewAll 13F holders of CCCCFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of CCCC by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−14,889−100.0%Sold outHolders
Q3 202514,889$33.1K<0.1%−2,150−12.6%ReducedHolders
Q2 202517,039$24.4K<0.1%+637+3.9%AddedHolders
Q1 202516,402$26.2K<0.1%+2,073+14.5%AddedHolders
Q4 202414,329$51.6K<0.1%−678−4.5%ReducedHolders
Q3 202415,007$85.5K<0.1%+185+1.2%AddedHolders
Q2 202414,822$68.5K<0.1%00.0%UnchangedHolders
Q1 202414,822$121.1K<0.1%00.0%UnchangedHolders
Q4 202314,822$83.7K<0.1%−33−0.2%ReducedHolders
Q3 202314,855$27.6K<0.1%−1,875−11.2%ReducedHolders
Q2 202316,730$46.0K<0.1%+1,388+9.0%AddedHolders
Q1 202315,342$48.2K<0.1%+15,342NewHolders
Q4 20220$00.0%−14,822−100.0%Sold outHolders
Q3 202214,822$130.0K<0.1%00.0%UnchangedHolders
Q2 202214,822$112.0K<0.1%00.0%UnchangedHolders
Q1 202214,822$360.0K<0.1%−4,940−25.0%ReducedHolders
Q4 202119,762$636.0K<0.1%−6,587−25.0%ReducedHolders
Q3 202126,349$1.18M<0.1%00.0%UnchangedHolders
Q2 202126,349$997.0K<0.1%+26,241+24,297.2%AddedHolders
Q1 2021108$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.